Pelvic Organ Prolapse (POP) Recruiting Phase 3 Trials for Tolterodine (DB01036)

Also known as: Pelvic Organ Prolapse

IndicationStatusPhase
DBCOND0052791 (Pelvic Organ Prolapse (POP))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02599311the Indications and Clinical Efficacy of Pelvic Organ Prolapse SurgeryTreatment